Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study
The BELIEVE study is the largest study to date demonstrating that retreatment with BV is an effective and well-tolerated option for patients with relapsed or refractory CD30-positive malignancies.
Authors
- Antonio M. Gutierrez (ORCID: https://orcid.org/0000-0001-9062-077X)
- Carmen Martı́nez (ORCID: https://orcid.org/0000-0002-8401-7306)
- Javier López‐Jiménez (ORCID: https://orcid.org/0000-0002-2969-3002)
- Antonia Rodríguez-Izquierdo (ORCID: https://orcid.org/0000-0001-6330-7729)
- M Grande (ORCID: https://orcid.org/0000-0003-1181-9479)
- Eva Domingo‐Doménech (ORCID: https://orcid.org/0000-0001-8907-090X)
- Pablo Luis Ortiz-Romero (ORCID: https://orcid.org/0000-0003-2985-9639)
- María Stefanía Infante (ORCID: https://orcid.org/0000-0003-0096-9359)
- Ramón García‐Sánz (ORCID: https://orcid.org/0000-0003-4120-2787)
- Pilar Giraldo (ORCID: https://orcid.org/0000-0002-8791-1901)
- Blanca Sánchez‐González (ORCID: https://orcid.org/0000-0002-7651-5049)
- Anna Sureda (ORCID: https://orcid.org/0000-0002-1238-6970)
- David Aguiar‐Bujanda (ORCID: https://orcid.org/0000-0002-5623-9315)
- Lourdes Baeza-Montañez
- F. Capote
Institutions
- Universidad de Alcalá (ES)
- Instituto Cajal (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Laboratorios Farmaceúticos Rovi (Spain) (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- Hospital Quirónsalud Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Del Mar (ES)
- Duran i Reynals Hospital (ES)
- Hospital Universitario Puerta del Mar (ES)
- Hospital Universitario Son Espases (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Hospital Universitario Infanta Leonor (ES)
Publication Details
- Journal
- Cancers
- Published
- 2025-03-28
- DOI
- https://doi.org/10.3390/cancers17071137
- Citations
- 3
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 6.01